Loading...
•
Jun 30, 2020
Zynex Q2 2020 Earnings Report
Reported highest quarterly revenue and continued profitability.
Key Takeaways
Zynex reported an 87% increase in net revenue to $19.3 million and a net income of $3.0 million for the second quarter of 2020. The company's order growth was 37% compared to the second quarter of 2019.
Net revenue increased by 87% compared to Q2 2019.
Net income was $3.0 million.
Orders grew 37% compared to the second quarter of 2019.
Cash from operations was $2.7 million.
Zynex
Zynex
Forward Guidance
The estimated range for third quarter revenue is between $22.3 and $22.8 million with Adjusted EBITDA between $2.3 and $2.8 million. Full year 2020 estimates are unchanged. Revenue is estimated between $80.0 and $85.0 million with Adjusted EBITDA between $15.0 and $18.0 million.
Positive Outlook
- Third quarter revenue is expected to increase by approximately 89% to 93% above 2019 third quarter revenue.
- Full year revenue is estimated to increase by approximately 76% to 87% above 2019 revenue.
- Third quarter revenue is estimated between $22.3 and $22.8 million.
- Third quarter Adjusted EBITDA is estimated between $2.3 and $2.8 million.
- Full year revenue is estimated between $80.0 and $85.0 million.
Challenges Ahead
- Third quarter revenue and Adjusted EBITDA estimates are impacted by lower than normal order growth in the second quarter of 2020 due to COVID-19.
- Third quarter revenue and Adjusted EBITDA estimates are impacted by continued investment in growing the sales force.
- COVID-19 pandemic impacting physician availability to prescribe products.
- COVID-19 pandemic impacting employee and supply chain issues.
- Lower than normal order growth in the second quarter of 2020 due to COVID-19.